Home | Welcome to Contract Pharma   
Last Updated Saturday, October 25 2014
Print RSS Feed

Breaking News

Kristin Brooks
February 19, 2014
To explore biomarkers and pathways in cardiovascular diseases   Read More »
February 19, 2014
13 prequalified companies will participate in program to enhance security of imported drugs  Read More »
Gil Roth
February 18, 2014
Capital investments reflect ongoing commitment to contract services  Read More »
Gil Roth
February 18, 2014
$25 bil. purchase will create $15 bil. company  Read More »
Gil Roth
February 18, 2014
Expands ADC characterization  Read More »
Gil Roth
February 18, 2014
Orantes to lead U.S. operations  Read More »
Gil Roth
February 18, 2014
Expands cancer immunotherapy, adds immune-modulating targets and technology  Read More »
Gil Roth
February 18, 2014
Will provide mammalian, microbial services to clinical-stage company  Read More »
Kristin Brooks
February 14, 2014
Attains growth in medical and specialty commercial markets  Read More »
Kristin Brooks
February 14, 2014
Catalent to provide commercial supply from Kansas City site  Read More »
Kristin Brooks
February 14, 2014
Hoffman brings more than 25 years of experience  Read More »
Kristin Brooks
February 14, 2014
Invests $200 million in SUB manufacturing infrastructure  Read More »
Kristin Brooks
February 14, 2014
Will discontinue Phase II study in colorectal cancer  Read More »
Kristin Brooks
February 14, 2014
To provide preclinical drug development through to Phase I - IV trials  Read More »
Kristin Brooks
February 13, 2014
Revenues up 8% in the quarter   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On